Biostate AI: Funding, Investors & Team (Sep 2026)
Biostate AI aims to create generative AI that can positively impact human health. We recognize that biological entities are constantly changing, with each person exhibiting slight variations from day to day. Get a discounted promotional RNAseq service for academia worth $10,000, now available for just $6,000.
Biostate AI has raised $12.0M across 2 funding rounds on record, the most recent a Series A of $12.0M announced in May 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Biostate AI Company Profile and Key Stats
Latest funding round on record: May 2025.
Biostate AI Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Biostate AI announced a Series A in Dec 2024; the amount was not disclosed.
5 months later, a Series A of $12.0M was announced in May 2025.
Biostate AI Founders and Leadership Team
Contact details for the Biostate AI team: 1 of 1 has an email address on file.
Start 14-day free trial →Biostate AI Funding Compared to Other Biotechnology Startups
Biostate AI's latest round of $12.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Biostate AI in Biotechnology and Palo Alto
Companies Similar to Biostate AI
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Biostate AI Funding FAQs
What does Biostate AI do?
Biostate AI aims to create generative AI that can positively impact human health. We recognize that biological entities are constantly changing, with each person exhibiting slight variations from day to day. Get a discounted promotional RNAseq service for academia worth $10,000, now available for just $6,000.
How much funding has Biostate AI raised?
Biostate AI has raised $12.0M across 2 rounds on record. The most recent is a Series A of $12.0M announced in May 2025.
When did Biostate AI last raise funding?
Biostate AI's most recent funding round on record is a Series A of $12.0M, announced in May 2025.
Who founded Biostate AI?
FundedIQ lists David Zhang (Founder) at Biostate AI.
Where is Biostate AI headquartered?
Biostate AI is based in Palo Alto, California, United States.
How many employees does Biostate AI have?
Biostate AI is in the 11-50 employee band.
How does Biostate AI's funding compare to other Biotechnology startups?
Biostate AI's latest round of $12.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Biostate AI Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biostate AI is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.